How the shortage of a $15 cancer drug is upending treatment

New York Times

26 June 2023 - Older generic chemotherapy drugs remain scarce, forcing doctors to put a priority on the patients who have the best chance of survival.

Tony Shepard learned he had vocal cord cancer this spring, but he was encouraged when his doctor said he had an 88 percent chance at a cure with chemotherapy and radiation.

That outlook began to dim in recent weeks, though, after the oncology practice he goes to in Central California began to sporadically run out of the critical medication he needs.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Supply